x

Search for a clinical trial

* (*) mandatory field

Setmelanotide (RM-493) Phase 2 Treatment Trial in Patients With Rare Genetic Disorders of Obesity

  • Type of clinical trial : Drug clinical trial
  • Recruiting project : Yes
  • Status : Ongoing trial
  • Funding body(ies) :
  • Geographic coverage : Global
  • Sponsor : Rhythm pharmaceuticals, inc.
  • Website
    • Phase : II - III
  • Principal investigator of clinical trial

  • Dr Tarekegn G HIWOT
  • Marshfield Clinic
  • University Hospital Birmingham
  • Mindelsohn Way, Edgbaston
  • BIRMINGHAM B15 2TH
  • UNITED KINGDOM
  • More information
  • Phone  : 44 (0)121 371 2000
  • Fax  : -
  • Website
Last update: February 2021

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.